These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24410895)

  • 1. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
    Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
    Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
    BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Verkerk-Tamminga R; Goossens PJ; van den Brink W; van Achterberg T
    Arch Psychiatr Nurs; 2015 Aug; 29(4):242-8. PubMed ID: 26165980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Busschbach J; van Achterberg T; van den Brink W
    BMC Psychiatry; 2015 Jul; 15():159. PubMed ID: 26169586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
    Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
    J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
    Regnart J; Truter I; Meyer A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):275-282. PubMed ID: 28686107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.
    Young S; Hollingdale J; Absoud M; Bolton P; Branney P; Colley W; Craze E; Dave M; Deeley Q; Farrag E; Gudjonsson G; Hill P; Liang HL; Murphy C; Mackintosh P; Murin M; O'Regan F; Ougrin D; Rios P; Stover N; Taylor E; Woodhouse E
    BMC Med; 2020 May; 18(1):146. PubMed ID: 32448170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD).
    Pehlivanidis A; Papanikolaou K; Mantas V; Kalantzi E; Korobili K; Xenaki LA; Vassiliou G; Papageorgiou C
    BMC Psychiatry; 2020 Aug; 20(1):423. PubMed ID: 32847520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder.
    Yule AM; DiSalvo M; Biederman J; Wilens TE; Dallenbach NT; Taubin D; Joshi G
    Eur Child Adolesc Psychiatry; 2023 Feb; 32(2):257-265. PubMed ID: 34363537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
    Manohar H; Kuppili PP; Kandasamy P; Chandrasekaran V; Rajkumar RP
    Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comorbidity of autism spectrum disorder and attention deficit with hyperactivity. A review study].
    Berenguer-Forner C; Miranda-Casas A; Pastor-Cerezuela G; Roselló-Miranda R
    Rev Neurol; 2015 Feb; 60 Suppl 1():S37-43. PubMed ID: 25726822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep in Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder.
    Singh K; Zimmerman AW
    Semin Pediatr Neurol; 2015 Jun; 22(2):113-25. PubMed ID: 26072341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders?
    Sizoo B; van den Brink W; Franke B; Vasquez AA; van Wijngaarden-Cremers P; van der Gaag RJ
    World J Biol Psychiatry; 2010 Aug; 11(5):699-708. PubMed ID: 20446882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
    Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
    Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.